- Corporate Officers - S
- Smith Scott Andrew
Insider Trading History of Smith Scott Andrew
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Smith Scott Andrew since 2015.
This trader's CIK number is 1614975.
At the time of last reporting, Smith Scott Andrew was the Chief Executive Officer of Viatris Inc. (stock ticker symbol VTRS).
Also see all insider trading activities at Viatris Inc.
Note that in the past
Smith Scott Andrew also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Viatris Inc (VTRS) by Smith Scott Andrew
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | VTRS | 82,000 | $756,016 | 0 | $0 | 243,131 | $0 |
| 2024 | VTRS | 0 | $0 | 0 | $0 | 140,727 | $0 |
Yearly summary of insider trading at Celgene Corp /de/ (CELG) by Smith Scott Andrew
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | CELG | 0 | $0 | 0 | $0 | 7,283 | $0 |
| 2017 | CELG | 0 | $0 | 0 | $0 | 8,410 | $0 |
| 2016 | CELG | 0 | $0 | 0 | $0 | 23,900 | $0 |
| 2015 | CELG | 0 | $0 | 0 | $0 | 21,666 | $0 |
Yearly summary of insider trading at Bioatla, Inc. (BCAB) by Smith Scott Andrew
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | BCAB | 0 | $0 | 42,307 | $1,570,746 | 0 | $0 |
Yearly summary of insider trading at F-star Therapeutics, Inc. (SBPH) by Smith Scott Andrew
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | SBPH | 12,000 | $49,080 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Smith Scott Andrew:
1. Viatris Inc (VTRS)
2. Celgene Corp /de/ (CELG)
3. Bioatla, Inc. (BCAB)
4. F-star Therapeutics, Inc. (SBPH)
Table 1. Insider trading of Viatris Inc (VTRS) by Smith Scott Andrew
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-08-12 | VTRS | Buy | 22,000 | 9.99 | 219,736 |
| 2025-05-12 | VTRS | Buy | 60,000 | 8.94 | 536,280 |
| 2025-03-03 | VTRS | Option Ex | 146,700 | .00 | 0 |
| 2025-03-04 | VTRS | Option Ex | 96,431 | .00 | 0 |
| 2024-03-03 | VTRS | Option Ex | 140,727 | .00 | 0 |
Table 2. Insider trading of Celgene Corp /de/ (CELG) by Smith Scott Andrew
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-02-17 | CELG | Option Ex | 7,283 | .00 | 0 |
| 2017-12-19 | CELG | Option Ex | 3,410 | .00 | 0 |
| 2017-07-28 | CELG | Option Ex | 5,000 | .00 | 0 |
| 2016-12-23 | CELG | Option Ex | 6,400 | .00 | 0 |
| 2016-12-02 | CELG | Option Ex | 3,750 | .00 | 0 |
| 2016-12-02 | CELG | Option Ex | 3,750 | .00 | 0 |
| 2016-04-29 | CELG | Option Ex | 10,000 | .00 | 0 |
| 2015-12-17 | CELG | Option Ex | 5,000 | .00 | 0 |
| 2015-12-03 | CELG | Option Ex | 10,000 | .00 | 0 |
| 2015-04-30 | CELG | Option Ex | 6,666 | .00 | 0 |
Table 3. Insider trading of Bioatla, Inc. (BCAB) by Smith Scott Andrew
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-12-02 | BCAB | Sale | 2,984 | 22.11 | 65,964 |
| 2021-11-30 | BCAB | Sale | 478 | 24.68 | 11,798 |
| 2021-12-01 | BCAB | Sale | 628 | 23.23 | 14,585 |
| 2021-11-29 | BCAB | Sale | 399 | 23.89 | 9,532 |
| 2021-11-22 | BCAB | Sale | 430 | 26.23 | 11,281 |
| 2021-11-23 | BCAB | Sale | 684 | 25.16 | 17,209 |
| 2021-11-24 | BCAB | Sale | 466 | 24.94 | 11,622 |
| 2021-10-01 | BCAB | Sale | 2,994 | 30.18 | 90,352 |
| 2021-08-26 | BCAB | Sale | 33,244 | 40.26 | 1,338,403 |
Table 4. Insider trading of F-star Therapeutics, Inc. (SBPH) by Smith Scott Andrew
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-06-28 | SBPH | Buy | 12,000 | 4.09 | 49,080 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Smith Scott Andrew
(Chief Executive Officer of Viatris Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.